These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
39 related articles for article (PubMed ID: 26105439)
21. Limited value of angiogenic factors in obese women. Loire P; Vicaut E; Cruaud P; Charnaux N; Carbillon L Pregnancy Hypertens; 2012 Oct; 2(4):368-70. PubMed ID: 26105604 [TBL] [Abstract][Full Text] [Related]
22. The Women's Health Diagnostic Gap. Gronowski AM; Yarbrough ML Endocrinology; 2018 Feb; 159(2):776-778. PubMed ID: 29325073 [TBL] [Abstract][Full Text] [Related]
23. [Preeclampsia in pregnancy - prediction, prevention and further management]. Leahomschi S; Calda P Ceska Gynekol; 2014 Nov; 79(5):356-62. PubMed ID: 25472453 [TBL] [Abstract][Full Text] [Related]
24. Circulating predictive biomarkers in preeclampsia. Staff AC Pregnancy Hypertens; 2011 Jan; 1(1):28-42. PubMed ID: 26104229 [TBL] [Abstract][Full Text] [Related]
25. Corrigendum to "Increased serum levels of sFlt-1/PlGF ratio in preeclamptic women with onset at <32 weeks compared with ≥32 weeks" [Pregnancy Hypertens. 12 (2018) 96-103]. Suzuki H; Hirashima C; Nagayama S; Takahashi K; Yamamoto T; Matsubara S; Ohkuchi A Pregnancy Hypertens; 2019 Jan; 15():181. PubMed ID: 30825919 [No Abstract] [Full Text] [Related]
26. Applying the concept of uncertainty to the sFlt-1/PlGF cut-offs for diagnosis and prognosis of preeclampsia. Lévy P; Hamdi S; Guibourdenche J; Haguet MC; Bailleul S; Lefèvre G Clin Chem Lab Med; 2021 Apr; 59(7):1331. PubMed ID: 33915607 [No Abstract] [Full Text] [Related]
27. Correction to: Prospective Evaluation of International Prediction of Pregnancy Complications Collaborative Network Models for Prediction of Preeclampsia: Role of Serum sFlt-1 at 11-13 Weeks' Gestation. Hypertension; 2022 Jul; 79(7):e113. PubMed ID: 35675442 [No Abstract] [Full Text] [Related]
28. Retracted: Correlation between 25-Hydroxyvitamin D, sFlt-1, PLGF, and Hypertension in Pregnancy. Healthcare Engineering JO J Healthc Eng; 2023; 2023():9843862. PubMed ID: 36714413 [TBL] [Abstract][Full Text] [Related]
29. PP086. The modern search for possible predictors of preeclampsia in the first trimester of pregnancy (preliminary study). Khodzhaeva ZS; Ivanets TY; Alexeeva ML; Kholin AM; Akatyeva AS; Vavina OV; Sukhikh GT Pregnancy Hypertens; 2012 Jul; 2(3):287. PubMed ID: 26105408 [TBL] [Abstract][Full Text] [Related]
30. PP058. The additive effect of plasma levels of sFlt-1/PLGF ratio following the risk classification using both blood pressure levels and uterine artery blood flow impedance in the second trimester on the later occurrence of preeclampsia. Ohkuchi A; Hirashima C; Takahashi K; Matsubara S; Suzuki M Pregnancy Hypertens; 2012 Jul; 2(3):273. PubMed ID: 26105381 [TBL] [Abstract][Full Text] [Related]
31. PP051. Prediction of preeclampsia with the sFlt-1/PLGF ratio: impact of the slope of repeated measurements. Schoofs K; Engels T; Pape J; Henrich W; Stepan H; Verlohren S Pregnancy Hypertens; 2012 Jul; 2(3):269. PubMed ID: 26105374 [TBL] [Abstract][Full Text] [Related]
32. PP052. The course of sFlt-1 and PLGF reflects different progression pattern in early- versus late-onset preeclampsia and HELLP syndrome. Schaarschmidt W; Rana S; Stepan H Pregnancy Hypertens; 2012 Jul; 2(3):269. PubMed ID: 26105375 [TBL] [Abstract][Full Text] [Related]
33. PP117. Measurement of sFlt-1 and PlGF for prediction of pregnancy associated diseases. Stubert J; Ullmann S; Bolz M; Bohlmann M; Külz T; Gerber B; Reimer T Pregnancy Hypertens; 2012 Jul; 2(3):303. PubMed ID: 26105439 [TBL] [Abstract][Full Text] [Related]